User menu

Intermediate-risk childhood acute lymphoblastic leukemias: amsacrine + cytosine arabinoside versus intermediate-dose methotrexate for consolidation, and 6-mercaptopurine + methotrexate + vincristine versus monthly pulses for maintenance.

Bibliographic reference Schaison, G. ; Leverger, G. ; Bancillon, A ; Marty, M ; Olive, D. ; et. al. Intermediate-risk childhood acute lymphoblastic leukemias: amsacrine + cytosine arabinoside versus intermediate-dose methotrexate for consolidation, and 6-mercaptopurine + methotrexate + vincristine versus monthly pulses for maintenance.. In: Haematology and blood transfusion, Vol. 30, p. 461-5 (1987)
Permanent URL http://hdl.handle.net/2078.1/27230